Document:

<PAGE>

                                                                    EXHIBIT 10.2
                           SECOND AMENDMENT TO THE LEASE

Commers-Klodt, a Minnesota General Partnership, Landlord, and Diametrics
Medical, Inc., a Minnesota Corporation, Tenant, entered into a Commercial Lease
(Lease) dated July 31, 1996, for the leased premises containing 31,433 square
feet of space located at 2640-2652 Patton Road, Roseville, Minnesota.

Both parties wish to amend this Lease as follows;

1.       TERM
         The term of this lease shall be extended by two (2) years and five (5)
         months commencing October 1, 2001, and terminate on February 28, 2004.

2.       RENT
         Beginning October 1, 2001, monthly Base Rent shall be amended as
         follows:

                  Term                                  Monthly Base Rent
         October 1, 2001 - February 28, 2003               $19,121.74
         March 1, 2003 - February 28, 2004                 $19,695.39

3.       IMPROVEMENTS
         Tenant shall submit to Landlord paid invoices and lien waivers for
         reimbursement up to $50,607.13 for improvements to the Demised
         Premises. Any costs incurred in excess of $50,607.13 shall be paid by
         Tenant.

All other terms, conditions and obligations outlined in the Lease remain in full
force and effect.

As agreed by:

LANDLORD:

COMMERS-KLODT,  a Minnesota General Partnership,

Signature:            /s/ Daniel P. Commers
----------------------------------------------------------------------------

Name:                   Daniel P. Commers
----------------------------------------------------------------------------

Title:                  Managing Partner                 Dated:     6/15/99
----------------------------------------------------------------------------

TENANT:

DIAMETRICS MEDICAL, INC. a Minnesota Corporation,
----------------------------------------------------------------------------

Signature:            /s/ Laurence L. Betterley
----------------------------------------------------------------------------

Name:                   Laurence L. Betterley
----------------------------------------------------------------------------

Title:                  Chief Financial Officer          Dated:     6/7/99
----------------------------------------------------------------------------
<PAGE>

                         SECOND AMENDMENT TO THE LEASE

Commers-Klodt, a Minnesota General Partnership, Landlord, and Diametrics
Medical, Inc., a Minnesota Corporation, Tenant, entered into a Commercial Lease
(Lease) dated July 31, 1996, for the leased premises containing 15,091 square
feet of space located at 2654-2662 Patton Road, Roseville, Minnesota.

Both parties wish to amend this Lease as follows;

1.       TERM
         The term of this lease shall be extended by four (4) years and five (5)
         months commencing October 1, 1999, and terminate on February 28, 2004.

2.       DEMISED PREMISES
         The Demised premises shall be reduced by 3,257 square feet (Bay 2662).
         The adjusted total for the Demised Premises shall be 11,834 square
         feet. Tenant shall vacate the reduction space not later than September
         30, 1999.

3.       RENT
         Beginning October 1, 1999, monthly Base Rent shall be amended as
         follows:

                  Term                                 Monthly Base Rent
         October 1, 1999 - February 28, 2002               $8,313.39
         March 1, 2002 - February 28, 2003                 $8,562.79
         March 1, 2003 - February 28, 2004                 $8,819.67

4.       IMPROVEMENTS
         Tenant shall submit to Landlord paid invoices and lien waivers for
         reimbursement up to $19,052.74 for improvements to the Demised
         Premises. Any costs incurred in excess of $19,052.74 shall be paid by
         Tenant.

All other terms, conditions and obligations outlined in the Lease remain in full
force and effect.

As agreed by:

LANDLORD:

COMMERS-KLODT,  a Minnesota General Partnership,

Signature:            /s/ Daniel P. Commers
----------------------------------------------------------------------------

Name:                   Daniel P. Commers
----------------------------------------------------------------------------

Title:                  Managing Partner                 Dated:     6/15/99
----------------------------------------------------------------------------

TENANT:

DIAMETRICS MEDICAL, INC. a Minnesota Corporation,

Signature:            /s/ Laurence L. Betterley
----------------------------------------------------------------------------

Name:                   Laurence L. Betterley
----------------------------------------------------------------------------

Title:                  Chief Financial Officer          Dated:     6/7/99
----------------------------------------------------------------------------<PAGE>

                                                                   Exhibit 10.22

                            STOCK PURCHASE AGREEMENT

     This Stock Purchase Agreement (the "Agreement") is entered into as of
November 29, 1999 by and between INTEL CORPORATION, a Delaware corporation
(together with its successors and permitted assigns, "Investor"), and ANCOR
COMMUNICATIONS, INCORPORATED, a Minnesota corporation (together with its
successors and permitted assigns, "Issuer"). Capitalized terms used but not
otherwise defined herein shall have the meanings set forth in Section 1.1.

     WHEREAS, subject to the terms and conditions of this Agreement, Investor
desires to purchase, and Issuer desires to issue and sell to Investor, shares of
Issuer's common stock, par value $.01 per share (the "Common Stock").

     NOW, THEREFORE, in consideration of the mutual representations, warranties,
covenants and agreements contained herein, the parties hereto agree as follows:

                                    ARTICLE I
                                   DEFINITIONS

     1.1 Defined Terms. As used herein the following terms shall have the
following meanings:

     "Affiliate" shall have the meaning ascribed to it in Rule 12b2 of the
General Rules and Regulations under the Exchange Act, as in effect on the date
hereof.

     "Articles of Incorporation" means Issuer's Articles of Incorporation, as
the same may be or have been supplemented, amended or restated from time to
time.

     "Bylaws" means Issuer's Restated Bylaws, as the same may be or have been
supplemented, amended or restated from time to time.

     "Contract" means any indenture, lease, sublease, loan agreement, mortgage,
note, restriction, commitment, obligation or other contract, agreement or
instrument.

     "Exchange Act" means the Securities Exchange Act of 1934, as amended.

     "GAAP" means generally accepted accounting principles in effect in the
United States of America from time to time.

     "Governmental Authority" means any nation or government, any state or other
political subdivision thereof, and any entity or official exercising executive,
legislative, judicial, regulatory or administrative functions of or pertaining
to government.

     "Lien" means any mortgage, pledge, security interest, encumbrance, lien or
charge of any kind (including any conditional sale or other title retention
agreement, any lease in the nature
<PAGE>

thereof, and the filing of or agreement to give a financing statement under the
Uniform Commercial Code or comparable law of any jurisdiction in connection with
such mortgage, pledge, security interest, encumbrance, lien or charge).

     "Material Adverse Change (or Effect)" means a change (or effect), in the
condition (financial or otherwise), properties, assets, liabilities, rights,
obligations, operations, business or prospects which change (or effect)
individually or in the aggregate with other such changes (or effects) is
materially adverse to such condition, properties, assets, liabilities, rights,
obligations, operations, business or prospects.

     "Person" means an individual, partnership, corporation, limited liability
company, business trust, joint stock company, estate, trust, unincorporated
association, joint venture, Governmental Authority or other entity, of whatever
nature.

     "Requirement of Law" means as to any Person, the articles of incorporation,
bylaws or other organizational or governing documents of such person, and any
domestic or foreign and federal, state or local law, rule, regulation, statute
or ordinance or determination of any arbitrator or a court or other Governmental
Authority, in each case applicable to or binding upon such Person or any of its
properties or to which such Person or any of its property is subject.

     "SEC" means the Securities and Exchange Commission.

     "Securities Act" means the Securities Act of 1933, as amended.

                                   ARTICLE II
                      ISSUANCE AND PURCHASE OF COMMON STOCK

     2.1 Issuance and Purchase of Common Stock. Subject to the terms and
conditions of this Agreement, Issuer will issue and sell to Investor, and
Investor will purchase from Issuer, a number of shares (the "Shares") of Common
Stock equal to the aggregate purchase price hereunder divided by the per share
purchase price, each as set forth herein, rounded up to the next whole number of
shares. The aggregate purchase price shall be $14,840,000. The per share
purchase price shall be equal to $53.00 (the "Purchase Price").

     2.2 Legend. Any certificate or certificates representing the Shares shall
bear the following legend:

     THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
     SECURITIES ACT OF 1933, AS AMENDED (THE "ACT") OR UNDER ANY APPLICABLE
     STATE SECURITIES LAW AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED
     OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION UNDER THE ACT OR AN OPINION
     OF COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT AND THE
     RULES AND REGULATIONS PROMULGATED THEREUNDER OR UNDER APPLICABLE STATE
     SECURITIES LAWS.

                                       2
<PAGE>

                                   ARTICLE III
                                     CLOSING

     3.1 Closing. The closing of the transactions contemplated herein (the
"Closing") shall take place as promptly as practicable after satisfaction or
waiver of the conditions set forth in Article VIII at the offices of Dorsey &
Whitney LLP, 220 South Sixth Street, Minneapolis, Minnesota 55402. At the
Closing, (i) Investor shall pay to Issuer, by wire transfer of immediately
available funds to an account designated in writing by Issuer, the Purchase
Price; (ii) Issuer shall issue to Investor the Shares, and deliver to Investor
certificates for the Shares duly registered in the name of Investor; and (iii)
all other agreements and other documents referred to in this Agreement shall be
executed and delivered (if not done prior to the Closing). "Closing Date" means
the date on which the Closing occurs.

                                   ARTICLE IV
                    REPRESENTATIONS AND WARRANTIES OF ISSUER

     As a material inducement to Investor entering into this Agreement and
purchasing the Shares, Issuer represents and warrants to Investor as follows:

     4.1 Corporate Status. Issuer is a corporation duly incorporated, validly
existing and in good standing under the laws of the State of Minnesota. Issuer
has all requisite corporate power and authority to own or lease, as the case may
be, its properties and to carry on its business as now conducted. Except as set
forth in Section 4.1 of the Disclosure Schedule attached hereto (the "Disclosure
Schedule"), the Issuer is qualified or licensed to conduct business and is in
good standing in all jurisdictions where its ownership or lease of property and
the conduct of its business requires such qualification or licensing, except to
the extent that failure to so qualify or be licensed would not have a Material
Adverse Effect on Issuer. There is no pending or threatened proceeding for the
dissolution, liquidation, or insolvency of Issuer.

     4.2 Corporate Power and Authority. Issuer has the corporate power and
authority to execute and deliver this Agreement and the other agreements,
instruments and documents contemplated hereby, and to perform its obligations
hereunder and to consummate the transactions contemplated hereby. Issuer has
taken all necessary corporate action to authorize the execution, delivery and
performance of this Agreement and the transactions contemplated hereby and the
authorization, issuance, reservation for issuance and delivery of all of the
Shares being sold under this Agreement have been or will be taken.

     4.3 Execution, Delivery and Enforceability. This Agreement has been duly
executed and delivered by Issuer and constitutes a legal, valid and binding
obligation of Issuer, enforceable against Issuer in accordance with its terms,
except as the same may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting the enforcement of

                                       3
<PAGE>

creditors' rights generally and general equitable principles regardless of
whether such enforceability is considered in a proceeding at law or in equity.

     4.4 No Violation. The execution and delivery by Issuer of this Agreement,
the consummation of the transactions contemplated hereby, and the compliance by
Issuer with the terms and provisions hereof (including, without limitation, the
issuance to Investor of the Shares), do not and will not result in a default
under (or give any other party the right, with the giving of notice or the
passage of time (or both), to declare a default or accelerate any obligation
under) or violate the Articles of Incorporation or Bylaws or any Contract to
which Issuer is a party or by which Issuer or its properties or assets are
bound, or any Requirement of Law applicable to Issuer, or result in the creation
or imposition of any Lien upon any of the capital stock, properties or assets of
Issuer.

     4.5 Consents/Approvals. Except for any filing and approval under the
HartScottRodino Antitrust Improvements Act of 1976, as amended, and the rules
and regulations thereunder ("HSR Act"), (a) no consents of, filings with or
authorizations or other actions of any Governmental Authority are required for
Issuer's execution, delivery and performance of this Agreement and (b) no
consent, approval, waiver or other action by any Person under any Contract to
which Issuer is a party or by which Issuer or any of its properties or assets
are bound is required or necessary for the execution, delivery or performance by
Issuer of this Agreement and the consummation of the transactions contemplated
hereby and thereby, except where the failure to obtain such consents would not
have a Material Adverse Effect on Issuer or would not invalidate the purchase of
the Shares.

     4.6 Capitalization. The authorized capital stock of Issuer consists of
40,000,000 shares of Common Stock, par value $.01 per share, and 5,000,000
shares of preferred stock, $.01 par value per share ("Preferred Stock"). As of
November 26, 1999, there are 28,045,520 shares of Common Stock and no shares of
Preferred Stock outstanding. All of the issued and outstanding securities of
Issuer have been duly authorized and validly issued and are fully paid and
nonassessable and are free of all liens, claims and encumbrances, other than
liens, claims or encumbrances create by, imposed upon or otherwise created by
the actions of the holders thereof. Issuer has no other equity securities or
securities containing any equity features authorized, issued or outstanding.
Except as set forth in Section 4.6 of the Disclosure Schedule, there are no
agreements or other rights or arrangements existing which provide for the sale
or issuance of capital stock by Issuer and there are no rights, subscriptions,
warrants, options, conversion rights or agreements of any kind outstanding to
purchase or otherwise acquire from Issuer any shares of capital stock or other
securities of Issuer of any kind. There are no agreements or other obligations
(contingent or otherwise) which may require Issuer to repurchase or otherwise
acquire any shares of its capital stock.

     4.7 Valid Issuance of Stock.

          (i) Valid Issuance. The Shares will be, upon payment therefor by the
     Investor in accordance with this Agreement, duly authorized, validly
     issued, fully paid and non-assessable.

                                       4
<PAGE>

          (ii) Compliance with Securities Laws. Assuming the correctness of the
     representations made by the Investor in Section Article V hereof, the
     Shares will be issued to the Investor in compliance with applicable
     exemptions from (i) the registration and prospectus delivery requirements
     of the Securities Act of 1933, as amended (the "Securities Act") and (ii)
     the registration and qualification requirements of all applicable
     securities laws of the states of the United States.

     4.8 SEC Reports and Nasdaq Compliance. Set forth in Section 4.8 of the
Disclosure Schedule is a complete and correct list of all registration
statements, reports and proxy statements filed by the Issuer with the SEC on or
after December 31, 1998. Issuer has made all filings (the "SEC Reports")
required to be made by it under the Securities Act, the Exchange Act and the
securities laws of any state, and any rules and regulations promulgated
thereunder and pursuant to any Requirements of Law. The SEC Reports, when filed,
complied in all material respects with all applicable requirements of the
Securities Act, the Exchange Act and other Requirements of Law. None of the SEC
Reports, at the time of filing, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or
necessary in order to make the statements therein not misleading in light of the
circumstances under which they were made. Issuer is not a party to any material
contract, agreement or other arrangement that was required to have been filed as
an exhibit to the SEC Reports that was not so filed. Issuer has taken all
necessary actions to ensure its continued inclusion in, and the continued
eligibility of the Common Stock for trading on the Nasdaq National Market under
all currently effective and currently proposed inclusion requirements.

     4.9 Governing Documents. Issuer has delivered or made available to Investor
true, accurate and complete copies of its Articles of Incorporation and Bylaws
in effect as of the date hereof.

     4.10 Subsidiaries. Issuer does not own, directly or indirectly, any
outstanding voting securities of or other interests in, and does not control,
any corporation, partnership, limited liability company, joint venture or other
business entity other than solely for investment purposes in connection with the
Company's current investment policy, nor does the Issuer own any outstanding
loan or advance to or from, any person or entity except as set forth in Section
4.10 of the Disclosure Schedule.

     4.11 Financial Statements. The Issuer has provided the Investor with copies
of its audited financial statements for the fiscal year ended December 31, 1998,
and its unaudited financial statements for the nine-month period ended September
30, 1999, which financial statements are included in the SEC Reports. Each of
the balance sheets included in the SEC Reports (including any related notes and
schedules) fairly presents in all material respects the consolidated financial
position of Issuer as of its date, and each of the other financial statements
included in the SEC Reports (including any related notes and schedules) fairly
presents in all material respects the consolidated financial condition, results
of operations, cash flows, or other information therein of Issuer for the
periods or as of the dates therein set forth in accordance with GAAP
consistently applied during the periods involved (except that the interim
reports are subject to normal

                                       5
<PAGE>

recurring adjustments which might be required as a result of year end audit and
except as otherwise stated therein).

     4.12 Changes Since September 30, 1999. Except as set forth in the SEC
Reports, since September 30, 1999, there has been no Material Adverse Change in
Issuer. Except as set forth in the SEC Reports or in Section 4.11 of the
Disclosure Schedule hereto, (a) since September 30, 1999, there has not been (i)
any direct or indirect redemption, purchase or other acquisition by Issuer of
any shares of Issuer's capital stock or (ii) declaration, setting aside or
payment of any dividend or other distribution by Issuer in respect of its
capital stock, or (iii) issuance of any shares of capital stock of Issuer or any
granting to any person of any option to purchase or other right to acquire
shares of capital stock of Issuer, other than the exercise or grant of employee
stock options pursuant to the Issuer's stock option plans and purchases pursuant
to the Issuer's employee stock purchase plan in the ordinary course of business
or (iv) any damage, destruction or loss, whether or not covered by insurance,
except for such occurrences, individually and collectively, that are not
material to the Issuer, or (v) any waiver by the Issuer of a valuable right or
of a material debt owed to it, except for such waivers, individually and
collectively, that are not material or (vi) any material change or amendment to,
or any waiver of any material right under a material contract or arrangement by
which the Issuer or any of its assets or properties is bound or subject, except
for changes, amendments or waivers that are expressly provided for or disclosed
in this Agreement or (vii) any change by the Issuer in its accounting
principles, methods or practices or in the manner it keeps its accounting books
and records, except any such change required by a change in GAAP; and (b) none
of the officers or directors of Issuer (or any of their spouses or children) has
(i) any direct or indirect investment or equity interest in, or power to control
the business affairs of, any manufacturer, supplier, lender or provider of
services or goods to Issuer, except for their interest in Issuer, (ii) any
material contractual relationship with Issuer, and (iii) has any direct or
indirect interest in any material right, property or asset which is owned or
used by Issuer in the conduct of its business.

     4.13 Environmental Matters. Except as set forth in the SEC Reports:

          (a) Issuer is and has at all times been in compliance with all
     Environmental Laws (as defined below) governing its business, operations,
     properties and assets, including, without limitation, Environmental Laws
     with respect to discharges into the ground water, surface water and soil,
     emissions into the ambient air, and generation, accumulation, storage,
     treatment, transportation, labeling or disposal of solid and hazardous
     waste materials and substances or process byproducts, in each case, for
     which failure to comply could have a Material Adverse Effect on Issuer.
     Issuer is not currently liable for any penalties, fines or forfeitures for
     failure to comply with any of the foregoing, which penalty, fine or
     forfeiture could have a Material Adverse Effect on Issuer. Issuer is in
     compliance with all notice, record keeping and reporting requirements of
     all Environmental Laws, and has complied with all informational requests or
     demands arising under the Environmental Laws, where failure to comply could
     have a Material Adverse Effect on Issuer.

                                       6
<PAGE>

          (b) As used in this Agreement, "Environmental Laws" means all federal,
     state or local laws, rules, regulations, orders or ordinances or judicial
     or administrative interpretations thereof, any of which govern (or purport
     to govern) or relate to air emissions, water discharges, hazardous or toxic
     substances, solid or hazardous waste and occupational health and safety, as
     any of these terms are or may be defined in such laws, rules, regulations,
     orders, or ordinances, or judicial or administrative interpretations
     thereof, including, without limitation, the Resource Conservation and
     Recovery Act, the Comprehensive Environmental Response, Compensation and
     Liability Act, as amended, by the Superfund Amendments and Reauthorization
     Act, the Hazardous Materials Transportation Act, the Toxic Substances
     Control Act, the Clean Air Act, the Clean Water Act and the Occupational
     Safety and Health Act.

     4.14 No Commissions. Issuer has not incurred any obligation for any finder,
broker or agent's fees or commissions in connection with the transactions
contemplated.

     4.15 Litigation. Except as set forth in Section 4.15 to the Disclosure
Schedule, there is no action, suit, proceeding, claim, arbitration or
investigation ("Action") pending or, to the best of the Issuer's knowledge,
threatened: (a) against the Issuer, its activities, properties or assets, or any
officer, director or employee of the Issuer in connection with such officer's,
director's or employee's relationship with, or actions taken on behalf of, the
Issuer, or (b) that seeks to prevent, enjoin, alter or delay the transactions
contemplated by this Agreement (including issuance of the Shares). The Issuer is
not a party to or subject to the provisions of any order, writ, injunction,
judgment or decree of any court or government agency or instrumentality. No
Action by the Issuer is currently pending nor does the Issuer intend to initiate
any Action that is reasonably likely to be material to the Issuer.

     4.16 Year 2000. To the best of Issuer's knowledge, all material computer
software and hardware used internally in the business of Issuer ("Business
Systems") will properly record, store, process, manage, specify and print four
digit dates (and data involving or based on four digit dates) falling on or
after January 1, 2000, in the same manner, and with the same functionality,
accuracy, data integrity and performance as such software and hardware record,
store, process, manage, specify and print calendar dates and date data (and data
utilizing or based on that data) falling on or before December 31, 1999. The
Business Systems will operate properly with other material software used
internally in the business of Issuer. All of the Issuer's material products
(including products currently under development) either (a) have no date
tracking or processing function, or (b) will record, store, process and
calculate and present calendar dates falling on and after December 31, 1999, and
will calculate any information dependent on or relating to such dates in the
same manner and with the same functionality, data integrity and performance as
the products record, store, process, calculate and present calendar dates on or
before December 31, 1999, or calculate any information dependent on or relating
to such dates (collectively, "Year 2000 Compliant"). All of the Issuer's
material products will lose no significant functionality with respect to the
introduction of records containing dates falling on or after December 31, 1999.
To the knowledge of the Issuer, all of the Issuer's material products and the
conduct of the Issuer's business with material customers and suppliers will not
be materially adversely affected by the advent of the year 2000, the advent of
the twenty-first

                                       7
<PAGE>

century or the transition from the twentieth century through the year 2000 and
into the twenty-first century. To the knowledge of the Issuer, the Issuer is not
reasonably likely to incur material expenses arising from or relating to the
failure of any of its Business Systems or any material products (including all
material products sold on or prior to the date hereof) as a result of the advent
of the year 2000, the advent of the twenty-first century or the transition from
the twentieth century through the year 2000.

     4.17 Compliance with Law and Charter Documents. The Issuer is not in
violation or default of any provisions of its Articles of Incorporation or
Bylaws, both as amended. The Issuer has complied in all material respects and is
in material compliance with all applicable statutes, laws, rules, regulations
and orders of the United States of America and all states thereof, foreign
countries and other governmental bodies and agencies having jurisdiction over
the Issuer's business or properties.

     4.18 Invention Assignment and Confidentiality Agreement. Except as set
forth in Section 4.18 of the Disclosure Schedule, each employee and consultant
or independent contractor of the Issuer whose duties include the development of
products or Intellectual Property (as defined below), and each former employee
and consultant or independent contractor whose duties included the development
of products or Intellectual Property who was initially employed or engaged by
Issuer on or after January 1, 1995, has entered into and executed an invention
assignment and confidentiality agreement in customary form or an employment or
consulting agreement containing substantially similar terms.

     4.19 Intellectual Property.

          (i) Ownership or Right to Use. The Issuer has sole title to and owns,
     or is licensed or otherwise possesses legally enforceable rights to use,
     all patents or patent applications, software, know-how, registered or
     unregistered trademarks and service marks and any applications therefor,
     registered or unregistered copyrights, trade names, and any applications
     therefor, trade secrets or other confidential or proprietary information
     ("Intellectual Property") necessary to enable the Issuer to carry on its
     business as currently conducted, except where any deficiency, or group of
     deficiencies, would not have a Material Adverse Effect.

          (ii) Licenses; Other Agreements. The Issuer is not currently the
     licensee of any material portion of the Intellectual Property of the
     Issuer. Except as set forth in Section 4.19 to the Disclosure Schedule,
     there are not outstanding any licenses or agreements of any kind relating
     to any Intellectual Property owned by the Issuer, except for agreements
     with customers of the Issuer entered into in the ordinary course of the
     Issuer's business and other licenses and agreements that, collectively, are
     not material. The Issuer is not obligated to pay any royalties or other
     payments to third parties with respect to the marketing, sale,
     distribution, manufacture, license or use of any Intellectual Property,
     except as the Issuer may be so obligated in the ordinary course of its
     business, as disclosed in the Issuer's SEC Documents or where the aggregate
     amount of such

                                       8
<PAGE>

     payments over the three year period following the date of this Agreement
     could not reasonably be expected to be material.

          (iii) No Infringement. The Issuer has not violated or infringed in any
     material respect, and is not currently violating or infringing in any
     material respect, and the Issuer has not received any communications
     alleging that the Issuer (or any of its employees or consultants) has
     violated or infringed, any Intellectual Property of any other person or
     entity.

          (iv) Employees and Consultants. To the best of the Issuer's knowledge,
     no employee of or consultant to the Issuer is in material default under any
     term of any material employment contract, agreement or arrangement relating
     to Intellectual Property of the Issuer or any material non-competition
     arrangement, other contract or restrictive covenant relating to the
     Intellectual Property of the Issuer. The Intellectual Property of the
     Issuer (other than any Intellectual Property duly acquired or licensed from
     third parties) was developed entirely by the employees of or consultants to
     the Issuer during the time they were employed or retained by the Issuer,
     and to the best knowledge of the Issuer, at no time during conception or
     reduction to practice of such Intellectual Property of the Issuer were any
     such employees or consultants operating under any grant from a government
     entity or agency or subject to any employment agreement or invention
     assignment or non-disclosure agreement or any other obligation with a third
     party that would materially and adversely affect the Issuer's rights in the
     Intellectual Property of the Issuer. Such Intellectual Property of the
     Issuer does not, to the best knowledge of the Issuer, include any invention
     or other intellectual property of such employees or consultants made prior
     to the time such employees or consultants were employed or retained by the
     Issuer nor any intellectual property of any previous employer of such
     employees or consultants nor the intellectual property of any other person
     or entity.

     4.20 Registration Rights. Issuer is not currently subject to any agreement
providing any person or entity any rights (including piggyback registration
rights) to have any securities of the Issuer registered with the SEC or
registered or qualified with any other governmental authority other than under
agreements for which registration statements are currently effective, which do
not conflict with the registration rights granted to Investor pursuant to the
Registration Rights Agreement referenced in Section 6.4.

     4.21 Title to Property and Assets. The non-leased properties and assets of
the Issuer are owned by the Issuer free and clear of all mortgages, deeds of
trust, liens, charges, encumbrances and security interests except for statutory
liens for the payment of current taxes that are not yet delinquent and liens,
encumbrances and security interests that are disclosed in the SEC Reports or
arise in the ordinary course of business and do not in any material respect
affect the properties and assets of the Issuer. With respect to the property and
assets it leases, the Issuer is in compliance with such leases in all material
respects.

     4.22 Tax Matters. The Issuer has filed all material tax returns required to
be filed, which returns are true and correct in all material respects, and the
Issuer has paid in full all taxes that

                                       9
<PAGE>

have become due on or prior to the date hereof (and will have paid when due all
taxes that become due after the date hereof and prior to the Closing), including
penalties and interest, assessments, fees and other charges, other than those
being contested in good faith and/or those for which adequate reserves have been
provided for.

     4.23 Full Disclosure. The information contained in this Agreement and any
other documents executed in connection with this Agreement and the SEC Reports
with respect to the business, operations, assets, results of operations and
financial condition of the Issuer, and the transactions contemplated by this
Agreement, are true and complete in all material respects and do not omit to
state any material fact or facts necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading.

                                    ARTICLE V
                   REPRESENTATIONS AND WARRANTIES OF INVESTOR

     As a material inducement to Issuer entering into this Agreement and issuing
the Shares, Investor represents and warrants to Issuer as follows:

     5.1 Corporate Status; Power and Authority. Investor is a corporation duly
organized, validly existing, and in good standing under the laws of Delaware.
Investor has the corporate power and authority to execute and deliver and to
perform its obligations under this Agreement and consummate the transactions
contemplated hereby. Investor has taken all necessary corporate action to
authorize the execution, delivery and performance of this Agreement and the
transactions contemplated hereby.

     5.2 No Violation. The execution and delivery by Investor of this Agreement,
the consummation of the transactions contemplated hereby, and the compliance by
Investor with the terms and provisions hereof, will not result in a default
under (or give any other party the right, with the giving of notice or the
passage of time (or both), to declare a default or accelerate any obligation
under) or violate the Certificate of Incorporation or Bylaws of Investor or any
Contract to which Investor is a party or by which it or its properties or assets
are bound, or violate any Requirement of Law applicable to Investor, other than
such violations, conflicts, defaults or breaches which, individually and in the
aggregate, do not and will not have a Material Adverse Effect on Investor.

     5.3 Consents/Approvals. Except for any filing and approval under the HSR
Act, (a) no consents, filings, authorizations or actions of any Governmental
Authority are required for Investor's execution, delivery and performance of
this Agreement, and (b) no consent, approval, waiver or other actions by any
Person under any Contract to which Investor is a party or by which Investor or
any of his properties or assets are bound is required or necessary for the
execution, delivery and performance by Investor of this Agreement and the
consummation of the transactions contemplated hereby.

     5.4 Enforceability. This Agreement has been duly executed and delivered by
Investor and constitutes a legal, valid and binding obligation of Investor,
enforceable against Investor in

                                       10
<PAGE>

accordance with its terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the
enforcement of creditor's rights generally and general equitable principles
regardless of whether enforceability is considered in a proceeding at law or in
equity.

     5.5 Investment Intent. Investor is acquiring the Shares for its own account
and with no present intention of distributing or selling such Shares in
violation of the Securities Act or any applicable state securities law. Investor
agrees that it will not sell or otherwise dispose of any of the Shares unless
such sale or other disposition has been registered under the Securities Act or,
in the opinion of counsel to Investor satisfactory to Issuer, is exempt from
registration under the Securities Act and has been registered or qualified or,
in the opinion of such counsel, is exempt from registration or qualification
under applicable state securities laws. Investor understands that the sale of
the Shares has not been registered under the Securities Act by reason of their
contemplated issuance in transactions exempt from the registration and
prospectus delivery requirements of the Securities Act pursuant to Section 4(2)
thereof, and that the reliance of Issuer on such exemption from registration is
predicated in part on the representations and warranties of Investor. Investor
acknowledges that pursuant to Section 2.2 a restrictive legend consistent with
the foregoing will be placed on the certificates for the Shares.

     5.6 Availability of Information; Ability to Evaluate Investment. Issuer has
made available to Investor the opportunity to ask questions and receive answers
concerning the business of Issuer and the terms and conditions of the purchase
of the Shares, including access to all reports and other filings made by Issuer
with the SEC and such other information as Investor deems necessary to evaluate
an investment in Issuer, and Investor as utilized such access and opportunity to
the extent believed by Investor to be necessary. Investor represents that it is
an accredited investor, as such term is defined in Regulation D promulgated
under the Securities Act, and has such knowledge and experience in financial and
business matters that Investor is able to evaluate the merits and risks of an
investment in Issuer.

     5.7 No Commissions. Investor has not incurred any obligation for any
finder, broker, or agent's fees or commissions in connection with the
transactions contemplated hereby.

     5.8 HSR Representations. Investor represents that it is acquiring the
Shares solely for purposes of investment. Without limiting the foregoing,
Investor specifically represents that it does not presently intend to (a)
nominate a candidate for election to the Board of Directors of Issuer, (b)
propose corporate action of Issuer requiring shareholder approval, (c) solicit
proxies with respect to any vote of the shareholders of Issuer or (d) have an
officer, director, or employee of Investor or any affiliate of Investor serve as
an officer or director of Issuer.

                                   ARTICLE VI
                                    COVENANTS

     6.1 Filings. Each of Investor and Issuer shall make on a prompt and timely
basis all governmental or regulatory notifications and filings required to be
made by it for the consummation of the transactions contemplated hereby.

                                       11
<PAGE>

     6.2 Obligations Regarding Confidential Information. Confidential
Information (as defined below) shall not be disclosed by any party hereto to any
third party except in accordance with the provisions set forth below. For
purposes of this Agreement, the term "Confidential Information" refers to (i)
the existence of this Agreement and (ii) the terms and provisions of this
Agreement, provided, however, that Confidential Information shall not include
any information that was (i) publicly known and generally available in the
public domain prior to its disclosure by the Company, (ii) becomes publicly
known and generally available in the public domain through no action or inaction
on the part of the Company in violation of the terms of this Agreement or (iii)
becomes publicly known by written consent or other action of the Investor.

          (a) Press Releases, Etc. Except as otherwise expressly permitted in
     this Section 6.2, no announcement regarding the Confidential Information in
     a press release, conference, advertisement, announcement, professional or
     trade publication, mass marketing materials or otherwise may be made by a
     party hereto without the prior written consent of the other party hereto.

          (b) Permitted Disclosures. Notwithstanding the foregoing, (i) either
     party may disclose any of the Confidential Information to its current or
     bona fide prospective investors, employees, investment bankers, lenders,
     accountants and attorneys, in each case only where such persons or entities
     are under appropriate nondisclosure obligations (provided that the
     disclosing party shall be responsible for any failure of any such person to
     comply with the provisions of this Section 6.2); and (ii) Investor may
     disclose its investment in Issuer and other Confidential Information to
     third parties or to the public at its sole discretion and, if it does so,
     Issuer shall have the right to disclose to third parties any such
     information disclosed in a press release or other public announcement by
     Investor.

          (c) Legally Compelled Disclosure. Except to the extent required by law
     or judicial or administrative order or except as provided herein, Issuer
     shall not disclose any Confidential Information without Investor's prior
     written approval; provided, however, that Issuer may disclose any
     Confidential Information, to the extent required by law or judicial or
     administrative order, provided that if such disclosure is pursuant to
     judicial or administrative order, Issuer will notify Investor promptly
     before such disclosure and will cooperate with Investor to seek
     confidential treatment with respect to the disclosure if requested by
     Investor and provided further that if such disclosure is required pursuant
     to law or the rules and regulations of any federal, state or local
     governmental authority or any regulatory body, if requested by Investor,
     Issuer will seek confidential treatment to the maximum extent, in the
     reasonable judgment of counsel of Issuer, possible under law.
     Notwithstanding the foregoing provisions or any other provision to the
     contrary, Issuer agrees that, except to the extent required by judicial or
     administrative order, which Issuer shall use its best efforts to avoid to
     the maximum extent possible under law, Issuer will not file this Agreement
     with any governmental authority or any regulatory body; provided, however,
     that to the extent required under the Securities Act, the Exchange Act or
     any of the rules and regulations promulgated thereunder, including judicial

                                       12
<PAGE>

     interpretations thereof (the "Rules and Regulations"), upon the advice of
     counsel, Issuer may (A) file this Agreement and the Registration Rights
     Agreement as an exhibit to any filing required to be made by the Company
     under the Securities Act or the Exchange Act and (B) in Issuer's filings
     under the Securities Act or the Exchange Act, identify Investor as "Intel
     Corporation" and describe the material terms of the Investor's investment.
     Issuer agrees that it will provide Investor with drafts of any documents,
     press releases or other filings (including the filing permitted by the
     proviso of the immediately preceding sentence) in which Issuer desires to
     disclose the terms of this Agreement, the transactions contemplated hereby
     or any other Confidential Information at least three (3) business days
     prior to the filing or disclosure thereof, and that it will cooperate with
     Investor to make any changes to such materials as requested by Investor
     unless advised by counsel that the Rules and Regulations require otherwise.
     Unless permitted by the terms of this Section, Issuer will not disclose any
     Confidential Information or file this Agreement if Investor has objected to
     such disclosure or filing. Issuer will not, except as permitted above, file
     this Agreement with any governmental authority or any regulatory body, or
     disclose the identity of the Investor or any other Confidential Information
     in any filing.

          (d) Other Information. The provisions of this Section 6.2 shall be in
     addition to, and not in substitution for, the provisions of any separate
     nondisclosure agreement executed by any of the parties hereto with respect
     to the transactions contemplated hereby. Additional disclosures and
     exchange of confidential information between Issuer and Investor shall be
     governed by the terms of the Corporate Non-Disclosure Agreement No.
     2284356, dated August 24, 1998, executed by Issuer and Investor, and any
     Confidential Information Transmittal Records (as defined in paragraph 1
     therein) provided in connection therewith.

     6.3 Confidential Information and Invention Assignment Agreement. Each of
Issuer's current key officers and employees have executed an Employee Disclosure
and Assignment Agreement as of the date hereof (the "Confidential Information
Agreement"). Issuer shall use its best efforts to cause all other of its current
employees who have not previously done so to execute a Confidential Information
Agreement.

     6.4 Registration Rights Agreement. As a condition of closing, the parties
shall enter into a Registration Rights Agreement in the form attached hereto as
Exhibit A (the "Registration Rights Agreement").

     6.5 Further Assurances. Each party shall execute and deliver such
additional instruments and other documents and shall take such further actions
as may be necessary or appropriate to effectuate, carry out and comply with all
of the terms of this Agreement and the transactions contemplated hereby.

     6.6 Notification of Certain Matters. Each party hereto shall give prompt
notice to the other party hereto of the occurrence, or nonoccurrence, of any
event which would be likely to cause any representation or warranty herein to be
untrue or inaccurate, or any covenant, condition or agreement herein not to be
complied with or satisfied.

                                       13
<PAGE>

     6.7 HSR Act and Other Actions. In the event a filing is required under the
HSR Act, each of the parties hereto shall (i) make promptly its respective
filings, and thereafter make any other required submissions, under the HSR Act,
with respect to the transactions contemplated hereby, and (ii) use its
reasonable best efforts to take, or cause to be taken, all appropriate actions,
and to do, or cause to be done, all things necessary, proper or advisable under
applicable laws and regulations to consummate and make effective the
transactions contemplated herein. Investor shall make payment of the applicable
HSR Act filing fee. The parties also agree to use their reasonable best efforts
to defend all lawsuits or other legal proceedings challenging this Agreement or
the consummation of the transactions contemplated hereby and to lift or rescind
any injunction or restraining order or other order adversely affecting the
ability of the parties to consummate the transactions contemplated hereby.

     6.8 Information Rights

          (i) Financial Information. The Issuer covenants and agrees that,
     commencing on the Closing and continuing for so long as the Investor holds
     more than 50% of the Shares purchased hereunder, the Issuer shall:

               (A) Annual Reports. Furnish to the Investor promptly following
          the filing of such report with the SEC a copy of the Issuer's Annual
          Report on Form 10-K for each fiscal year, which shall include a
          consolidated balance sheet as of the end of such fiscal year, a
          consolidated statement of income and a consolidated statement of cash
          flows of the Issuer and its subsidiaries for such year, setting forth
          in each case in comparative form the figures from the Issuer's
          previous fiscal year, all prepared in accordance with generally
          accepted accounting principles and practices and audited by nationally
          recognized independent certified public accountants. In the event the
          Issuer shall no longer be required to file Annual Reports on Form
          10-K, the Issuer shall, within ninety (90) days following the end of
          each respective fiscal year, deliver to the Investor a copy of such
          balance sheets, statements of income and statements of cash flows.

               (B) Quarterly Reports. Furnish to the Investor promptly following
          the filing of such report with the SEC, a copy of each of the Issuer's
          Quarterly Reports on Form 10-Q, which shall include a consolidated
          balance sheet as of the end of the respective fiscal quarter,
          consolidated statements of income and consolidated statements of cash
          flows of the Issuer and its subsidiaries for the respective fiscal
          quarter and for the year to-date, setting forth in each case in
          comparative form the figures from the comparable periods in the
          Issuer's immediately preceding fiscal year, all prepared in accordance
          with generally accepted accounting principles and practices (except,
          in the case of any Form 10-Q, as may otherwise be permitted by Form
          10-Q), but all of which may be unaudited. In the event the Issuer
          shall no longer be required to file Quarterly Reports on Form 10-Q,
          the Issuer shall, within forty-five (45) days following the end of
          each of the first three (3) fiscal quarters of each fiscal year,
          deliver to the

                                       14
<PAGE>

          Investor a copy of such balance sheets, statements of income and
          statements of cash flows.

          (ii) SEC Filings. The Issuer shall deliver to the Investor copies of
     each other document filed with the SEC on a non-confidential basis promptly
     following the filing of such document with the SEC.

     6.9 Restrictions on Transfer. Investor agrees not to sell, transfer,
assign, pledge or otherwise dispose of all or any portion of the Shares unless
and until (a) there is then in effect a registration statement under the
Securities Act and any applicable state securities laws covering such proposed
disposition and such disposition is made in accordance with such registration
statement; or (b) such disposition may lawfully be made without registration
under the securities Act or qualification under applicable state securities laws
exempt from the registration requirements of the Securities Act and any
applicable state securities laws covering such proposed disposition and, if
requested by Issuer, Investor shall provide Issuer with an opinion of counsel
reasonably satisfactory to Issuer to that effect prior to any such disposition.
Notwithstanding the foregoing, in no event shall Investor dispose of any or all
of the Shares for a period of six months from the date of this agreement.

                                   ARTICLE VII
                                 INDEMNIFICATION

     7.1 Agreement to Indemnify.

          (i) Company Indemnity. The Investor, its Affiliates and Associates,
     and each officer, director, shareholder, employer, representative and agent
     of any of the foregoing (collectively, the "Investor Indemnitees") shall
     each be indemnified and held harmless to the extent set forth in this
     Section 7 by the Issuer with respect to any and all Damages (as defined
     below) incurred by any Investor Indemnitee as a proximate result of any
     inaccuracy or misrepresentation in, or breach of, any representation,
     warranty, covenant or agreement made by the Issuer in this Agreement
     (including any exhibits and schedules hereto).

          (ii) Investor Indemnity. The Issuer, its respective Affiliates and
     Associates, and each officer, director, shareholder, employer,
     representative and agent of any of the foregoing (collectively, the "Issuer
     Indemnitees") shall each be indemnified and held harmless to the extent set
     forth in this Section 7, by the Investor, in respect of any and all Damages
     incurred by any Issuer Indemnitee as a proximate result of any inaccuracy
     or misrepresentation in, or breach of, any representation, warranty,
     covenant or agreement made by the Investor in this Agreement.

          (iii) Equitable Relief. Nothing set forth in this Section 7 shall be
     deemed to prohibit or limit any Investor Indemnitee's or Issuer
     Indemnitee's right at any time before, on or after the Closing, to seek
     injunctive or other equitable relief for the failure of any

                                       15
<PAGE>

     Indemnifying Party to perform or comply with any covenant or agreement
     contained herein.

     7.2 Survival. All representations and warranties of the Investor and the
Issuer contained herein and all claims of any Investor Indemnitee or Issuer
Indemnitee in respect of any inaccuracy or misrepresentation in or breach
hereof, shall survive the Closing until the third anniversary of the date of
this Agreement, regardless of whether the applicable statute of limitations,
including extensions thereof, may expire. All covenants and agreements of the
Investor and the Issuer contained in this Agreement shall survive the Closing in
perpetuity (except to the extent any such covenant or agreement shall expire by
its terms). All claims of any Investor Indemnitee or Issuer Indemnitee in
respect of any breach of such covenants or agreements shall survive the Closing
until the expiration of three years following the date on which such breach
occurs.

     7.3 Claims for Indemnification. If any Investor Indemnitee or Issuer
Indemnitee (an "Indemnitee") shall believe that such Indemnitee is entitled to
indemnification pursuant to this Section 7 in respect of any Damages, such
Indemnitee shall give the appropriate Indemnifying Party (which for purposes
hereof, in the case of an Investor Indemnitee, means the Issuer, and in the case
of a Issuer Indemnitee, means the Investor) prompt written notice thereof. Any
such notice shall set forth in reasonable detail and to the extent then known
the basis for such claim for indemnification. The failure of such Indemnitee to
give notice of any claim for indemnification promptly shall not adversely affect
such Indemnitee's right to indemnity hereunder except to the extent that such
failure adversely affects the right of the Indemnifying Party to assert any
reasonable defense to such claim.

     Each such claim for indemnity shall expressly state that the Indemnifying
Party shall have only the twenty (20) business day period referred to in the
next sentence to dispute or deny such claim. The Indemnifying Party shall have
twenty (20) business days following its receipt of such notice either (a) to
acquiesce in such claim by giving such Indemnitee written notice of such
acquiescence or (b) to object to the claim by giving such Indemnitee written
notice of the objection. If the Indemnifying party does not object thereto
within such twenty (20) business day period, such Indemnitee shall be entitled
to be indemnified for all Damages reasonably and proximately incurred by such
Indemnitee in respect of such claim. If the Indemnifying Party objects to such
claim in a timely manner, the senior management of the Issuer and the Investor
shall meet to attempt to resolve such dispute. If the dispute cannot be resolved
by the senior management, either party may make a written demand for formal
dispute resolution and specify therein the scope of the dispute. Within thirty
(30) days after such written notification, the parties agree to meet for one (1)
day with an impartial mediator and consider dispute resolution alternatives
other than litigation. If an alternative method of dispute resolution is not
agreed upon within thirty days after the one day mediation, either party may
begin litigation proceedings. Nothing in this section shall be deemed to require
arbitration.

     7.4 Defense of Claims. In connection with any claim that may give rise to
indemnity under this Section 7 resulting from or arising out of any claim or
Proceeding against an Indemnitee by a person or entity that is not a party
hereto, the Indemnifying Party may (unless

                                       16
<PAGE>

such Indemnitee elects not to seek indemnity hereunder for such claim) but shall
not be obligated to, upon written notice to the relevant Indemnitee, assume the
defense of any such claim or Proceeding if the Indemnifying Party with respect
to such claim or Proceeding acknowledges to the Indemnitee the Indemnitee's
right to indemnity pursuant hereto to the extent provided herein (as such claim
may have been modified through written agreement of the parties); provided,
however, that nothing set forth herein shall be deemed to require the
Indemnifying Party to waive any cross-claims or counterclaims the Indemnifying
Party may have against the Indemnified Party for damages. The Indemnified Party
shall be entitled to retain separate counsel, reasonably acceptable to the
Indemnifying Party, if the Indemnified Party shall determine, upon the written
advice of counsel, that an actual or potential conflict of interest exists
between the Indemnifying Party and the Indemnified Party in connection with such
Proceeding. The Indemnifying Party shall be obligated to pay the reasonable fees
and expenses of such separate counsel to the extent the Indemnified Party is
entitled to indemnification by the Indemnifying Party with respect to such claim
or Proceeding under this Section 7.4. If the Indemnifying Party assumes the
defense of any such claim or Proceeding, the Indemnifying Party shall select
counsel reasonably acceptable to such Indemnitee to conduct the defense of such
claim or Proceeding, shall take all steps necessary in the defense or settlement
thereof and shall at all times diligently and promptly pursue the resolution
thereof. If the Indemnifying Party shall have assumed the defense of any claim
or Proceeding in accordance with this Section 7.4, the Indemnifying Party shall
be authorized to consent to a settlement of, or the entry of any judgment
arising from, any such claim or Proceeding, with the prior written consent of
such Indemnitee, not to be unreasonably withheld; provided, however, that the
Indemnifying Party shall pay or cause to be paid all amounts arising out of such
settlement or judgment concurrently with the effectiveness thereof; provided
further, that the Indemnifying party shall not be authorized to encumber any of
the assets of any Indemnitee or to agree to any restriction that would apply to
any Indemnitee or to its conduct of business; and provided further, that a
condition to any such settlement shall be a complete release of such Indemnitee
and its Affiliates, directors, officers, employees and agents with respect to
such claim, including any reasonably foreseeable collateral consequences
thereof. Such Indemnitee shall be entitled to participate in (but not control)
the defense of any such action, with its own counsel and at its own expense.
Each Indemnitee shall, and shall cause each of its Affiliates, directors,
officers, employees and agents to, cooperate fully with the Indemnifying Party
in the defense of any claim or Proceeding being defended by the Indemnifying
Party pursuant to this Section 7.4. If the Indemnifying Party does not assume
the defense of any claim or Proceeding resulting therefrom in accordance with
the terms of this Section 7.4, such Indemnitee may defend against such claim or
Proceeding in such manner as it may deem appropriate, including settling such
claim or Proceeding, but only with the prior written consent of the Indemnifying
Party, which may not be unreasonably withheld, on such terms as such Indemnitee
may deem appropriate. If any Indemnifying Party seeks to question the manner in
which such Indemnitee defended such claim or Proceeding or the amount of or
nature of any such settlement, such Indemnifying Party shall have the burden to
prove by a preponderance of the evidence that such Indemnitee did not defend
such claim or Proceeding in a reasonably prudent manner.

     7.5 Certain Definitions. As used in this Section 7, (a) "Affiliate" means,
with respect to any person or entity, any person or entity directly or
indirectly controlling, controlled by or under

                                       17
<PAGE>

direct or indirect common control with such other person or entity; (b)
"Associate" means, when used to indicate a relationship with any person or
entity, (1) any other person or entity of which such first person or entity is
an officer, director or partner or is, directly or indirectly, the beneficial
owner of ten percent (10%) or more of any class of equity securities, membership
interests or other comparable ownership interests issued by such other person or
entity, (2) any trust or other estate in which such first person or entity has a
ten percent (10%) or more beneficial interest or as to which such first person
or entity serves as trustee or in a similar fiduciary capacity, and (3) any
relative or spouse of such first person or entity who has the same home as such
first person or entity or who is a director or officer of such first person or
entity; (c) "Damages" means all demands, claims, actions or causes of action,
assessments, losses, damages, costs, expenses, liabilities, judgments, awards,
fines, response costs, sanctions, taxes, penalties, charges and amounts paid in
settlement, including (1) interest on cash disbursements in respect of any of
the foregoing at the prime rate of Chase Manhattan Bank, as in effect from time
to time, compounded quarterly, from the date each such cash disbursement is made
until the date the party incurring such cash disbursement shall have been
indemnified in respect thereof, and (2) reasonable out-of-pocket costs, fees and
expenses (including reasonable costs, fees and expenses of attorneys,
accountants and other agents of, or other parties retained by, such party), and
(d) "Proceeding" means any action, suit, hearing, arbitration, audit, proceeding
(public or private) or investigation that is brought or initiated by or against
any federal, state, local or foreign governmental authority or any other person
or entity.

                                  ARTICLE VIII
                              CONDITIONS TO CLOSING

     8.1 Conditions to Obligation of Each Party to Effect the Closing. The
respective obligations of each party to effect the Closing shall be subject to
the fulfillment of the following conditions any and all of which may be waived,
in whole or in part, to the extent permitted by applicable law:

          (a) No Order. No governmental authority or other agency or commission
     or federal or state court of competent jurisdiction shall have enacted,
     issued, promulgated, enforced or entered any statute, rule, regulation,
     executive order, decree, injunction, or other order (whether temporary,
     preliminary or permanent) which is in effect and which materially
     restricts, prevents or prohibits consummation of the Closing or any
     transaction contemplated by this Agreement; provided, however, that the
     parties shall use their reasonable best efforts to cause any such decree,
     judgment, injunction or other order to be vacated or lifted; and

          (b) HartScottRodino Act. In the event a filing is required pursuant to
     the HSR Act, any waiting period (and any extension thereof) applicable to
     the consummation of the Closing under the HSR Act shall have expired or
     been terminated.

          (c) Collaboration Agreement. The parties shall have entered into the
     Collaboration Agreement to be entered into between the parties on or prior
     to the date hereof.

                                       18
<PAGE>

     8.2 Additional Conditions to the Obligations of Investor. The obligation of
Investor to proceed with the Closing is also subject to the following conditions
any and all of which may be waived, in whole or in part, to the extent permitted
by applicable law:

          (a) Representations and Warranties. Each of the representations and
     warranties of Issuer contained in this Agreement shall be true and correct
     as of the Closing as though made on and as of the Closing, except for
     changes specifically permitted by this Agreement. Investor shall have
     received a certificate of an officer of Issuer to such effect;

          (b) Agreement and Covenants. Issuer shall have performed or complied
     in all material respects with all agreements and covenants required by this
     Agreement to be performed or complied with by it on or prior to the
     Closing. Investor shall have received a certificate of an officer of Issuer
     to such effect;

          (c) Registration Rights Agreement. Issuer shall have executed the
     Registration Rights Agreement.

          (d) Opinion of Counsel. Counsel to the Issuer shall have delivered an
     opinion of counsel, dated as of the Closing Date, in form and substance
     agreed to by Investor.

          (e) Securities Exemptions. The offer and sale of the Shares to the
     Investor pursuant to this Agreement shall be exempt from the registration
     requirements of the Securities Act and the registration and/or
     qualification requirements of all applicable state securities laws.

          (f) Proceedings and Documents. All corporate and other proceedings in
     connection with the transactions contemplated at the Closing and all
     documents incident thereto shall be reasonably satisfactory in form and
     substance to the Investor, and the Investor shall have received all such
     counterpart originals and certified or other copies of such documents as it
     may reasonably request. Such documents shall include but not be limited to
     the following:

               (i) Certified Charter Documents. A copy of (i) the Articles of
          Incorporation certified as of a recent date by the Secretary of State
          of Minnesota as a complete and correct copy thereof, and (ii) the
          Bylaws of the Issuer (as amended through the date of the Closing)
          certified by the Secretary of the Issuer as a true and correct copy
          thereof as of the Closing.

               (ii) Board Resolutions. A copy, certified by the Secretary of the
          Issuer, of the resolutions of the Board of Directors of the Issuer
          providing for the approval of this Agreement and the issuance of the
          Shares, and the other matters contemplated hereby and thereby.

                                       19
<PAGE>

               (iii) Registrar and Transfer Agent Certificate. A certificate,
          executed by the Issuer's registrar and transfer agent certifying the
          number of outstanding shares of Common Stock of the Issuer as of a
          recent date reasonably acceptable to the Investor.

          (g) Nasdaq Requirements. All requirement of the Nasdaq National Market
     in connection with the transactions contemplated by this Agreement shall
     have been complied with by the Issuer.

          (h) Executive Committee Approval. The Investor shall have obtained the
     approval from its Executive Committee (in its sole discretion) of the
     purchase of the Shares and the consummation of the transactions
     contemplated by this Agreement.

          (i) Other Actions. The Issuer shall have executed such certificates,
     agreements, instruments and other documents, and taken such other actions
     as shall be customary or reasonably requested by the Investor in connection
     with the transactions contemplated hereby.

     8.3 Additional Conditions to the Obligations of Issuer. The obligation of
Issuer to proceed with the Closing is also subject to the following conditions
any and all of which may be waived, in whole or in part, to the extent permitted
by applicable law:

          (a) Representations and Warranties. Each of the representations and
     warranties of Investor contained in this Agreement shall be true and
     correct as of the Closing Date as though made on and as of the Closing
     Date, except (i) for changes specifically permitted by this Agreement, and
     (ii) that those representations and warranties which address matters only
     as of a particular date shall remain true and correct as of such date.
     Issuer shall have received a certificate of an officer of Investor to such
     effect;

          (b) Agreement and Covenants. Investor shall have performed or complied
     in all material respects with all agreements and covenants required by this
     Agreement to be performed or complied with by it on or prior to the
     Closing. Issuer shall have received a certificate of an officer of Investor
     to such effect;

          (c) Registration Rights Agreement. Investor shall have executed the
     Registration Rights Agreement.

          (d) Securities Exemptions. The offer and sale of the Shares to the
     Investor pursuant to this Agreement shall be exempt from the registration
     requirements of the Securities Act and the registration and/or
     qualification requirements of all applicable state securities laws.

          (e) Proceedings and Documents. All corporate and other proceedings in
     connection with the transactions contemplated at the Closing and all
     documents incident thereto will be reasonably satisfactory in form and
     substance to the Issuer and to the

                                       20
<PAGE>

     Issuer's legal counsel, and the Issuer will have received all such
     counterpart originals and certified or other copies of such documents as it
     may reasonably request.

          (f) Nasdaq Requirements. All requirements of the Nasdaq National
     Market in connection with the transactions contemplated by this Agreement
     shall have been complied with.

                                   ARTICLE IX
                                  MISCELLANEOUS

     9.1 Notices. All notices, requests, demands, claims, and other
communications hereunder shall be in writing, shall be effective when received,
and shall in any event be deemed received and effectively given upon: personal
delivery to the party to be notified or three (3) business days after mailing by
certified or registered mail (first class postage prepaid), or one (1) business
day after sent by guaranteed overnight delivery, or upon receipt of confirmation
of successful transmission if by facsimile, to the following addresses and
facsimile numbers (or to such other addresses or facsimile numbers which such
party shall designate in writing to the other party):

    (a)  if to Issuer to:       Ancor Communications, Incorporated
                                6321 Bury Drive, Suite 13
                                Eden Prairie, Minnesota  55346
                                Attention: Chief Executive Officer
                                Fax: (612) 932-4037
                                Telephone: (612) 932-4000

    with a copy to:             Dorsey & Whitney, LLP
                                Pillsbury Center South
                                220 South Sixth Street
                                Minneapolis, Minnesota 554021498
                                Attention:  Amy E. Ayotte, Esq.
                                Fax:  (612) 3408738
                                Telephone:(612) 3402600

    (b)  if to Investor to:     Intel Corporation
                                2200 Mission College Blvd.
                                Santa Clara, CA 95052
                                Attention: Portfolio Manager - Mail Stop RN6-46
                                Fax: 408-765-6038
                                Telephone: (408) 765-5636

                                       21
<PAGE>

    with a copy to:             Intel Corporation
                                CBD Legal Maintenance (Joanne Field)
                                2200 Mission College Blvd., SC4-203
                                Santa Clara, CA 95052
                                Telephone: (408) 765-8080
                                Facsimile: (408) 653-7093

     9.2 Entire Agreement. This Agreement and the Registration Rights Agreement
(including the Exhibits and Schedules attached hereto and thereto) and the
documents to be delivered at the Closing pursuant hereto, contain the entire
understanding of the parties in respect of its subject matter and supersede all
prior agreements and understandings between or among the parties with respect to
such subject matter. The Exhibits and Schedules hereto constitute a part hereof
as though set forth in full above.

     9.3 Expenses; Taxes. Except as otherwise provided in this Agreement, the
parties shall pay their own fees and expenses, incurred in connection with this
Agreement or any transaction contemplated hereby; provided, however, that Issuer
shall, concurrently with the Closing, pay to Investor $15,000 for Investor's
expenses in connection with the transactions contemplated by this Agreement.

     9.4 Amendment; Waiver. This Agreement may not be modified, amended,
supplemented, canceled or discharged, except by written instrument executed by
both parties. No failure to exercise, and no delay in exercising, any right,
power or privilege under this Agreement shall operate as a waiver, nor shall any
single or partial exercise of any right, power or privilege hereunder preclude
the exercise of any other right, power or privilege. No waiver of any breach of
any provision hereunder shall be deemed to be a waiver of any preceding or
succeeding breach of the same or any other provision, nor shall any waiver be
implied from any course of dealing between the parties. No extension of time for
performance of any obligations or other acts hereunder, or under any other
agreement shall be deemed to be an extension of the time for performance of any
other obligations or any other acts.

     9.5 Binding Effect; Assignment. The rights and obligations of this
Agreement shall bind and inure to the benefit of the parties and their
respective successors and legal assigns. The rights and obligations of this
Agreement may not be assigned by any party without the prior written consent of
the other party.

     9.6 Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be an original but all of which together shall
constitute one and the same instrument.

     9.7 Headings. The headings contained in this Agreement are for convenience
of reference only and are not to be given any legal effect and shall not affect
the meaning or interpretation of this Agreement. All references in this
Agreement to sections, paragraphs, exhibits and schedules will, unless otherwise
provided, refer to sections and paragraphs hereof

                                       22
<PAGE>

and exhibits and schedules attached hereto, all of which exhibits and schedules
are incorporated herein by this reference.

     9.8 Governing Law; Interpretation. This Agreement shall be construed in
accordance with and governed for all purposes by the laws of the State of
Minnesota without reference to principles of conflict of laws or choice of laws.

     9.9 Severability. The parties stipulate that the terms and provisions of
this Agreement are fair and reasonable as of the date hereof. However, if any
provision of this Agreement shall be determined by a court of competent
jurisdiction to be invalid, void or unenforceable, the remainder of the terms,
provisions, covenants and restrictions of this Agreement shall remain in full
force and effect and shall in no way be affected, impaired or invalidated. If,
moreover, any of those provisions shall for any reason be determined by a court
of competent jurisdiction to be unenforceable because excessively broad or vague
as to duration, geographical scope, activity or subject, it shall be construed
by limiting, reducing or defining it, so as to be enforceable.

     9.10 No Finder's Fees. The Investor will indemnify and hold harmless the
Issuer from any liability for any commission or compensation in the nature of a
finders' or broker's fee for which the Investor or any of its officers,
partners, employees or consultants, or representatives is responsible. The
Issuer will indemnify and hold harmless the Investor from any liability for any
commission or compensation in the nature of a finder's or broker's fee for which
the Issuer or any of its officers, employees or consultants or representatives
is responsible.

     9.11 Further Assurances. From and after the date of this Agreement upon the
request of the Issuer or the Investor, the Issuer and the Investor will execute
and deliver such instruments, documents or other writings, and take such other
actions, as may be reasonably necessary or desirable to confirm and carry out
and to effectuate fully the intent and purposes of this Agreement.

     9.12 Competition. Nothing set forth herein shall be deemed to preclude,
limit or restrict the Issuer's or the Investor's ability to compete with the
other.

                                      * * *

                                       23
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have caused this Stock Purchase
Agreement to be duly executed and delivered as of the day and year first above
written.

                                       Issuer:

                                       ANCOR COMMUNICATIONS,
                                       INCORPORATED

                                       By: /s/ Steven E Snyder
                                           -------------------------------------
                                       Print Name:  Steven E Snyder
                                                    ----------------------------
                                       Title: CFO
                                              ----------------------------------

                                       Investor:

                                       INTEL CORPORATION

                                       By: /s/ Arvind Sodhani
                                           -------------------------------------
                                       Print Name: Arvind Sodhani
                                                   -----------------------------

                                       Title: Vice President and Treasurer
                                              ----------------------------------

                                       24

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00006-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00006-of-00352.parquet"}]]